Biotech Archives - Page 112 of 795

2 minute read

With Bumper $33B Sales, Novo Nordisk Forecasts Double-Digit 2024 Earnings Growth, Boosts Lower Dose Wegovy US Supplies

January 31, 9:38 AM

Novo Nordisk reports impressive Q4 2023 sales of DKK 65.86 billion, up 43% at CER. Explore robust growth in Diabetes and Obesity care, including GLP-1 diabetes and Wegovy. CEO anticipates continued success in 2024 with sales growth of 18%-26% .

NVO

2 minute read

Why Is European Pharma Giant Novartis Stock Trading Lower Today?

By Vandana Singh

January 31, 9:16 AM

Novartis Q4 2023 sales reach $11.42 billion, up 8%. Strong growth in key drugs, Entresto, Kisqali, Kesimpta, Cosentyx, and Pluvicto. Core operating income at $3.8 billion.

NVS

2 minute read

Novo Nordisk Skyrockets To $506B Valuation Driven By ‘Miracle’ Drugs Ozempic, Wegovy

By Benzinga Neuro

January 31, 7:57 AM

The company predicts a sales growth of 18% to 26% in CER terms for the current year, driven by the soaring demand for Wegovy and Ozempic, which contain the same active ingredient.

NVO

3 minute read

‘Rainforests Are Nature’s Medicine Cabinets’: Biotech Co. Performs Fresh Research On Traditional Plants For Modern Mental Health Challenges

By Lara Goldstein

January 30, 2:52 PM

Numerous companies in the psychedelics industry are essentially advancing research on compounds that have a history of past…

FLHLF

2 minute read

Why Is Vertex Pharmaceuticals Stock Sliding Today?

By Vandana Singh

January 30, 10:51 AM

Explore Vertex Pharmaceuticals' Phase 3 results for VX-548, a NaV1.8 inhibitor, demonstrating significant pain relief post-surgery.

VRTX

2 minute read

Pfizer Surprises With Q4 Profit Despite Muted COVID Products Demand, Sticks To 2024 Guidance

By Vandana Singh

January 30, 9:48 AM

Pfizer's Q4 2023 financial report: adjusted EPS beats estimates at $0.10, FY2023 EPS down 72%, Q4 sales decline 41% to $14.25B. CEO's positive outlook and reaffirmed 2024 guidance.

PFE

2 minute read

Pharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock Soars

By Vandana Singh

January 30, 7:27 AM

Arcus Biosciences sees a 17.1% surge as Gilead Sciences amends collaboration, investing $320M at $21.00/share. Accelerate joint programs in cancer therapy.

GILD

1 minute read

Vanda Pharmaceuticals Announced Court Granted Vanda’s Motion For Summary Judgment On Its Claim Against The FDA

By Charles Gross

January 29, 8:08 PM

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that the United States District Court for the District of Columbia granted Vanda's motion for summary judgment on its claim against the United States

VNDA

2 minute read

AbbVie’s Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures

By Vandana Singh

January 29, 3:04 PM

AbbVie's growth outlook in 2024 as William Blair upgrades, highlighting strong performance in Humira erosion management, strategic acquisitions, and a 3.8% dividend yield.

ABBV

2 minute read

Eli Lilly Wants to Expand Access to Weight-Loss Treatments In Germany, In Talks With Government

By Vandana Singh

January 29, 2:14 PM

Eli Lilly in talks with German government to lift ban on health system coverage for weight-loss treatments. Explore Mounjaro's recent EU approval and market launches.

LLY